K2 Principal Fund’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

K2 Principal Fund’s Portfolio TDACW Stock Details TDACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$143K	Sell	101,034 -95,425	-49%	-$95.8K	0.01%	358
2026 Q1	$23.6K	Sell	196,459 -49,230	-20%	-$11.3K	﹤0.01%	434
2025 Q4	$76.2K	Sell	245,689 -50,000	-17%	-$16.4K	0.01%	337
2025 Q3	$85.8K	Hold	295,689	–	–	0.01%	279
2025 Q2	$68K	Hold	295,689	–	–	0.01%	244
2025 Q1	$41.4K	Buy	+295,689	New	+$52K	0.01%	278

Other funds holding TDACW

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 21.9% 1-Year Est. Return

K2 Principal Fund's TDACW Position: Q2 2026 in Review

K2 Principal Fund reduced its Translational Development Acquisition Corp Warrants (TDACW) stake by 49% in Q2 2026, selling an estimated $95.8K and leaving 101,034 shares worth $143K. The position accounts for 0.01% of the portfolio, ranked #358.

K2 Principal Fund first reported a position in TDACW in Q1 2025 and has held it in 6 quarters since. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

K2 Principal Fund held 101,034 shares of Translational Development Acquisition Corp Warrants worth $143K as of Q2 2026.
K2 Principal Fund sold 95,425 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $95.8K.
Translational Development Acquisition Corp Warrants made up 0.01% of K2 Principal Fund's portfolio in Q2 2026, its #358 holding.
K2 Principal Fund first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 6 quarters since.
28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on K2 Principal Fund's 13F filing for Q2 2026, filed 7 Aug 2026.